Improvement of global longitudinal strain and myocardial work in type 2 diabetes patients on sodium-glucose cotransporter 2 inhibitors therapy
Anno:
2024
Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2-i) are a novel class of oral hypoglycaemic agents currently used among patients with type 2 diabetes mellitus (T2DM). The effects of SGLT2-i inhibitors on cardiac structure and function are not fully understood. The aim of the present study is to evaluate the echocardiographic…